- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 83.41M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 83.35M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 83.14M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 83.25M sh |
| Stock Repurchased | Q2 2026 · Mar 31, 2026 | $4.01M |
| Stock Repurchased | Q2 2026 · Mar 31, 2025 | $4M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | $87.61M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | $62.93M |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $519M |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $518.08M |
| Long Term Debt | Q2 2026 · Mar 31, 2025 | $517.19M |
| Short Term Debt | Q2 2026 · Mar 31, 2026 | $0 |
| Short Term Debt | Q2 2026 · Sep 30, 2025 | $0 |
| Short Term Debt | Q2 2026 · Mar 31, 2025 | $103.33M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $354.18M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $469.52M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $505.24M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2024 | $170.51M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $1.12B |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $1.03B |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $851.58M |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $231.75M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $200.57M |
| Current Liabilities | Q2 2026 · Mar 31, 2025 | $264.04M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $984.83M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $925.72M |
| Total Liabilities | Q2 2026 · Mar 31, 2025 | $978.05M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $1.09B |
| Current Assets | Q2 2026 · Sep 30, 2025 | $1.13B |
| Current Assets | Q2 2026 · Mar 31, 2025 | $1.07B |
| Total Assets | Q2 2026 · Mar 31, 2026 | $2.13B |
| Total Assets | Q2 2026 · Sep 30, 2025 | $1.95B |
| Total Assets | Q2 2026 · Mar 31, 2025 | $1.83B |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $0.61 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $1.17 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $0.33 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $0.74 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $0.80 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $1.52 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $0.46 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $1.03 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $34.49M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $61.23M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $25.1M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $49.28M |
| Net Income | Q2 2026 · Mar 31, 2026 | $49.1M |
| Net Income | Q2 2026 · Mar 31, 2026 | $93.41M |
| Net Income | Q2 2026 · Mar 31, 2025 | $25.39M |
| Net Income | Q2 2026 · Mar 31, 2025 | $56.41M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $67.84M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $128.45M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $34.25M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $76.19M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $260.04M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $483M |
| Gross Profit | Q2 2026 · Mar 31, 2025 | $178.45M |
| Gross Profit | Q2 2026 · Mar 31, 2025 | $363.86M |
| Revenue | Q2 2026 · Mar 31, 2026 | $446.88M |
| Revenue | Q2 2026 · Mar 31, 2026 | $828.9M |
| Revenue | Q2 2026 · Mar 31, 2025 | $306.32M |
| Revenue | Q2 2026 · Mar 31, 2025 | $626.49M |